There are currently no accurate statistics on the chances of curing acute leukemia in the elderly. However, some surveys have found that as the age of elderly patients with acute leukemia increases, the rate of complete remission with clinical treatment will decrease significantly. The symptoms of acute leukemia in the elderly are generally more insidious, such as weakness, dizziness, low fever and other symptoms, and there may also be unexplained anemia, which is usually diagnosed only after several months of illness. As all the body functions of the elderly are degraded to varying degrees, stem cell transplantation is often not possible, and low-dose standardized chemotherapy (cytarabine, zorubicin) is recommended. It has been found that with the increase in age of elderly patients, the complete remission rate of clinical treatment is significantly lower, and the mortality rate in the early stage of chemotherapy is higher. However, with the improvement of medical standards, in recent years, some studies have found that individualized chemotherapy regimens are more conducive to the treatment of elderly patients (Vinaclat, Azacitidine). Therefore, when the elderly suffer from acute leukemia, it is recommended that they actively seek medical attention, and under the guidance of the physician to receive individualized treatment, which is conducive to prolonging the survival time.